These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9379433)

  • 1. NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.
    Hajduk PJ; Dinges J; Miknis GF; Merlock M; Middleton T; Kempf DJ; Egan DA; Walter KA; Robins TS; Shuker SB; Holzman TF; Fesik SW
    J Med Chem; 1997 Sep; 40(20):3144-50. PubMed ID: 9379433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.
    Hegde RS; Androphy EJ
    J Mol Biol; 1998 Dec; 284(5):1479-89. PubMed ID: 9878365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions.
    Liang H; Petros AM; Meadows RP; Yoon HS; Egan DA; Walter K; Holzman TF; Robins T; Fesik SW
    Biochemistry; 1996 Feb; 35(7):2095-103. PubMed ID: 8652551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
    Hines CS; Meghoo C; Shetty S; Biburger M; Brenowitz M; Hegde RS
    J Mol Biol; 1998 Mar; 276(4):809-18. PubMed ID: 9500925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 transactivation domain by photoaffinity labeling and mass spectrometry.
    Davidson W; McGibbon GA; White PW; Yoakim C; Hopkins JL; Guse I; Hambly DM; Frego L; Ogilvie WW; Lavallée P; Archambault J
    Anal Chem; 2004 Apr; 76(7):2095-102. PubMed ID: 15053675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.
    Stubenrauch F; Zobel T; Iftner T
    J Virol; 2001 May; 75(9):4139-49. PubMed ID: 11287563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunit rearrangement accompanies sequence-specific DNA binding by the bovine papillomavirus-1 E2 protein.
    Hegde RS; Wang AF; Kim SS; Schapira M
    J Mol Biol; 1998 Mar; 276(4):797-808. PubMed ID: 9500927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and determination of the absolute configuration of a series of potent inhibitors of human papillomavirus type-11 E1-E2 protein-protein interaction: a combined medicinal chemistry, NMR and computational chemistry approach.
    Goudreau N; Cameron DR; Déziel R; Haché B; Jakalian A; Malenfant E; Naud J; Ogilvie WW; O'meara J; White PW; Yoakim C
    Bioorg Med Chem; 2007 Apr; 15(7):2690-700. PubMed ID: 17306550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the cellular CCAAT displacement protein and human papillomavirus E2 protein with the viral origin of replication can regulate DNA replication.
    Narahari J; Fisk JC; Melendy T; Roman A
    Virology; 2006 Jul; 350(2):302-11. PubMed ID: 16529788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics of the DNA-binding domain of the papillomavirus E2 transcriptional regulator uncover differential properties for DNA target accommodation.
    Falconi M; Santolamazza A; Eliseo T; de Prat-Gay G; Cicero DO; Desideri A
    FEBS J; 2007 May; 274(9):2385-95. PubMed ID: 17403036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.
    Kurg R; Tekkel H; Abroi A; Ustav M
    J Virol; 2006 Nov; 80(22):11218-25. PubMed ID: 16943289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the BPV-1 E2 DNA-binding domain bound to its DNA target.
    Hegde RS
    J Nucl Med; 1995 Jun; 36(6 Suppl):25S-27S. PubMed ID: 7769463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of DNA structure and dynamics in the recognition of bovine papillomavirus E2 protein target sequences.
    Djuranovic D; Oguey C; Hartmann B
    J Mol Biol; 2004 Jun; 339(4):785-96. PubMed ID: 15165850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.
    Huth JR; Yu L; Collins I; Mack J; Mendoza R; Isaac B; Braddock DT; Muchmore SW; Comess KM; Fesik SW; Clore GM; Levens D; Hajduk PJ
    J Med Chem; 2004 Sep; 47(20):4851-7. PubMed ID: 15369388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase.
    Faucher AM; White PW; Brochu C; Grand-Maître C; Rancourt J; Fazal G
    J Med Chem; 2004 Jan; 47(1):18-21. PubMed ID: 14695816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2.
    Heino P; Zhou J; Lambert PF
    Virology; 2000 Oct; 276(2):304-14. PubMed ID: 11040122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo.
    Kurg R; Uusen P; Sepp T; Sepp M; Abroi A; Ustav M
    Virology; 2009 Apr; 386(2):353-9. PubMed ID: 19232665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.
    Fujii T; Austin D; Guo D; Srimatkandada S; Wang T; Kubushiro K; Masumoto N; Tsukazaki K; Nozawa S; Deisseroth AB
    Clin Cancer Res; 2003 Nov; 9(14):5423-8. PubMed ID: 14614029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitors of the human papillomavirus E1-E2 interaction.
    White PW; Faucher AM; Goudreau N
    Curr Top Microbiol Immunol; 2011; 348():61-88. PubMed ID: 20676971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the intact transactivation domain of the human papillomavirus E2 protein.
    Antson AA; Burns JE; Moroz OV; Scott DJ; Sanders CM; Bronstein IB; Dodson GG; Wilson KS; Maitland NJ
    Nature; 2000 Feb; 403(6771):805-9. PubMed ID: 10693813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.